GB2316404A - Palladium catalysed indolization - Google Patents
Palladium catalysed indolization Download PDFInfo
- Publication number
- GB2316404A GB2316404A GB9716979A GB9716979A GB2316404A GB 2316404 A GB2316404 A GB 2316404A GB 9716979 A GB9716979 A GB 9716979A GB 9716979 A GB9716979 A GB 9716979A GB 2316404 A GB2316404 A GB 2316404A
- Authority
- GB
- United Kingdom
- Prior art keywords
- 6alkyl
- process according
- alkyl
- palladium
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A process for preparing a compound of formula III wherein ```R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are each substituents that will not interfere with the reaction conditions, provided that R6 is not H, comprising reacting a compound of formula I with a compound of formula II: wherein Y is selected from Br, I, and triflate, and ```R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are as defined above, in the presence of a palladium catalyst and a proton acceptor. Still further, the present invention is also directed to the novel intermediates of formulae (IV) and (V).
Description
TITLE OF THE INVENTION
PALLADIUM CATALYZED EDOLIZATION BACKGROUND OF THE INvENTION
The present invention relates to the preparation of indoles from the palladium catalyzed reaction of 2-halo- and 2trifluoromethylsulfonyl- anilines and ketones. In one embodiment of the present invention, cyclic ketones are employed. This embodiment is particularly useful in preparing tetrahydrocarbazole derivatives and related compounds. In another embodiment of the present invention, substituted alkyl ketones are employed. This embodiment is particularly useful in preparing 2, 3, di-substituted indole derivatives, useful in the preparation of indomethacin and certain lipooxygenase inhibitors. Thus, the process of the present invention is useful in preparing biologically active compounds.
Generally, indoles are prepared via the Fischer-indole reaction. For example, Chen et al., J. Org. Chem., 59:3738 (1994) disclose the preparation of N,N-dimethyl tryptamines from 4-substituted hydrazines and dimethyl amino acetal using 4% H2S04. However, the yields are often low, particularly for compounds having triazole substitution. Benzyltriazoles are unstable to the Fischer indole reaction conditions, which generally lead to polymerization of the triazole moiety, and the production of oligomers.
Larock et al., J. Am. Chem. Soc., 113:6689 (1991) have shown that coupling of an iodoaniline species with an internal acetylene using palladium catalysis gives 2,3-disubstituted indoles in good-toexcellent yields. Smith et al ., have also demonstrated this for 4pyrimidinyl and pyridinyl derivatives of indol-3-yl-aLkyl piperazines as in published EPO 548 831 Al. Two other applications of this methodology have been demonstrated in the syntheses of hetero-condensed pyrroles and tryptophans. See Wensbo et al., Tetrahedron Lett., 34:2823 (1993);
Wensbo et al., Tetrahedron Lett., 34:6471 (1993). However, all of these methods require triphenylphosphine, as part of the catalyst system, which is an environmental hazard. An alternate process has been developed to overcome the low yield of the Fischer-indole reaction with certain starting materials and to avoid the use of the environmentally hazardous triphenylphosphine. This process is detailed in PCT publication WO 95/32197 and involves the palladium-catalyzed coupling/ring closure of a 3-iodo-4-aminobenzyltriazole with a suitably protected butynol derivative to the corresponding tryptophol, followed by conversion of the hydroxyethyl moiety to a dimethyl amino ethyl; as shown below:
said process being carried out in a dry inert organic solvent for the starting materials at a temperature in the range of about 70 to 1200C, in the presence of a palladium catalyst, and in the presence of an inorganic or organic amine compound, wherein:
X21 and X22 are independently ring nitrogen or carbon atoms;
halo represents Br or I;
n is an integer from 0-1;
p is an integer from 14;
R23 is H or linear or branched C1-C4 alkyl;
R21 is H or a radical with functions as a hydroxy protecting group,
which is removable, under mild acid hydrolyses, for
example, by contacting with a mixture of HCl/MeOH, e.g.
1:1 2N HCVMeOH at 0-30"C, and
R22 is a radical which functions as a terminal acetylene carbon
protecting group.
However, although the chemistry of this alternate process is effective, the starting materials, butynol and triethylsilyl chloride, are relatively expensive. The present invention provides for a cost-effective indolization procedure.
Iida et al., J. Org. Chem. 45:2938-2942 (1980) describe intramolecular cyclization of 3-((2-bromoaryl)amino) cyclohex-2-en-1ones with catalytic palladium in the presence of triphenyl phosphine, as well as the reaction of aryl amines with p-diketones to form the corresponding secondary enaminone followed by N-ethylation to form the corresponding tertiary enaminones and subsequent intramolecular cyclization in the presence of equimolar palladium acetate.
Sakamota et al., Synthesis, p. 215-218 (1990), describe palladium- catalyzed cyclization of P -(2-halophenyl)amino substituted o:,p-unsaturated ketones and esters to produce 2,3-disubstituted indoles.
The procedure of Sakamota et al., also employs phosphine.
Indole is a common feature of a variety of natural products, many of which possess potent biological activities. Hence, indoles are attractive synthetic targets. When substituted alkyl ketones are employed in the process of the present invention, the present invention has particular application in the synthesis of and 2,3-disubstituted indoles, including the precursor to indomethacin, shown below.
I ndomethaci n I ndomethacin precursor
When cyclic ketones are employed in the process of the present invention the present invention has particular application in the synthesis of tetrahydrocarbazole derivatives and homologs and analogs thereof. In particular, the precursor to the antidepressant iprindole may be made according to the process of the present invention.
Iprindole Iprindole precursor
Thus, the present invention also provides for an efficient and cost-effective synthesis of pharmaceutically active indole derivatives useful in the treatment of disease.
SUMMARY OF THE INVENTION
We have found that indoles of structural formula (m):
can be cost-effectively synthesized in high yield by the palladiumcatalyzed coupling/ring closure of a 2-halo or 2-trifluoromethylsulfonyl aniline and an alkyl ketone derivative. The process of the present invention is particularly useful to form indoles containing acid-labile substituents such as triazole, acetyl, ketal, cyano, and carbamate, or indoles having a good leaving group in the benzyl position. The advantages of the present process are that it does not require the use of triphenyl phosphine or tetrabutyl ammonium chloride or lithium chloride.
By this invention, there is provided a process comprising the step of contacting a compound of Structure I with a compound of
Structure II to form a compound of StructureIII:
wherein Y is selected from Br, I, and triflate, and
R1, R2, R3, R4, R5, and R6 are each substituents that will
not interfere with the reaction conditions.
More particularly, the present invention relates to the reaction above wherein:
Y is selected from Br, I and triflate;
R1, R2, R3 and R4 are each independently selected from:
(1) hydrogen;
(3) C1 6 alkyl; (4) -(CH2)n-Z
wherein Z represents:
(a) fluoro,
(b) cyano,
(c) triazole,
(d) nitro,
(e) trifluoromethyl,
(f) -OR7, (g) -OCOR7, 01)OCONR7R8 (i) -OCH2CN, (j) -OCH2CONR7R8, (k) -SR7, (1) -SOR7, (m) -SO2R7, (n) -SO2NR7R8, (o) -NR7R8, (p) -NR7COR8, (q) -NR7CO2R8, (r) -NR7SO2R8, (s) -COR7, (t) -CO2R7, (u) -CONR7R8,
Or a group of formula (Za), (Zb), (Zc), or (Zd):
or Z represents an optionally substituted five-membered
heteroaromatic ring selected from faran, thiophene,
pyrrole, oxazole, thiazole, isoxazole, isothiazole,
imidazole, pyrazole, oxadiazole, thiadiazole, triazole
and tetrazole;
R5 and R6 are each independently selected from:
(1) hydrogen,
(2) C1-6 alkyl,
(3) -CO2CH2CH3,
(4) 1,4-dioxaspiro, and
(5) C1-6 alkyl substituted with R10;
R7 and R8 are each independently selected from:
(1) hydrogen,
(2) C1-6 alkyl,
(3) trifluoromethyl,
(4) phenyl, optionally substituted with one or more R20
substituents
(5) methylphenyl, optionally substituted with one or more
R20 substituents, and
(6) an arylC1-6alkyl- or heteroaryl C1-6alkyl- group.
optionally substituted with one or more R20
substituents, or
R7and R8 when linked through a nitrogen atom, together
represent the residue of an optionally substituted
azetidine, pyrrolidine, piperidine, morpholine or
piperazine ring, optionally substituted with one or
more R13 substituents;
R9 is selected from:
(1) hydrogen, and
(2) ClA alkyl;
R10is selected from:
(1) halogen,
(2) cyano,
(3) trifluoromethyl,
(4) C1.6alkyl, (5) haloCl 6alkyl-,
(6) aryl,
(7) triazolyl,
(8) tetrazolyl,
(9) Cl 6alkyl-tetrazolyl-, (10) hydroxy,
(11) C1-6alkoxy-,
(12) C1-6alkylthio-,
(13) C2 6alkoxycarbonyl-, (14) C2-6alkylcarbonyl-, (15) C1-6alkylsulphonyl-, (16) arylsulfonyl-, (17) amino-, (18) C1 -6alkylamino-, (19) diC1-6alkylamino-, (20) diC 1 6alkylaminomethyl-, (21) C2-6alkylcarbonylamino-, (22) arylcarbonylamino-, (23) C2.6alkoxycarbonylamino-, (24) N-C1-6alkyl-N-C2-6alkoxyamino-, (25) carbonylamino-, (26) mono- or diarylaminocarbonylamino-, (27) pyrrolidinylcarbonylamino-, (28) piperidinylcarbonylamino-, (29) aminocarbonyl-, (30) aminocarbonylamino-, (31) Cl 6alkylaminocarbonyl-, (32) C1-6lalkylaminocarbonylamino-, (33) diC1-6alkylaminocarbonyl-, (34) diCl -6alkylaminocarbonyiamino-, (35) pyrrolidinylcarbonylamino-, (36) piperidinylcarbonylamino-, (37) aminosulfonyl-, (38) C1-6alkylaminosulfonyl-, (39) C1-6alkylsulfonylamino-, (40) C1-6alkylsulfonylaminoethyl-, (41) arylsulfonylamino-, (42) diC1-6alkylaminosulfonyl-, (43) aminosulphonylmethyl-, (44) C1 -6alkylaminosulfonylmethyl- and (45) diC1-6alkylaminosulfonylmethyl-, (46) -(CH2)mOR11, (47) -(CH2)mSR11, (48) -(CH2)mSOR11 (49) -(CH2)mSO2R1 1, (50) -(CH2)mNR11R12, (51) =0, and
Rll and R12 are each independently selected from
(1) hydrogen,
(2) Cl 6alkyl, (3) C3 7cycloalkyl, (4) C3-7cycloalkylC1-6alkyl-,
(5) indanyl,
(6) aryl,
(7) arylCl.6alkyl-, (8) C3-7heterocycloalkyl-,
(9) C3-7heterocycloalkylC1-6alkyl-,
(10) heteroaryl, and
(11) heterorylC1-6alkyl-;
R13 is selected from:
(1) C1-6alkyl,
(2) arylCl 6alkyl-, (3) C1-6alkoxy-,
(4) C26alkyoxycarbonyl-, and
(5) C1-6alkylaminocarbonyl;
X1 and X2 are each independently selected from ring nitrogen or
ring carbon atoms;
X3 is selected from the group consisting of oxygen, sulfur, -NH- or
methylene;
Y is oxygen or sulfur; n is an integer independently selected at each occurrence from
from 0 and 1; and
m is an integer selected independetlyat each occurrence from 0 to
4.
The process is preferably carried out in a dry organic solvent inert for the starting materials at a temperature range of 90-120"C in the presence of a palladium catalyst, and in the presence of a proton acceptor which may be an inorganic or organic amine compound.
Where Z in the compounds of formula I above represents a five-membered heteroaromatic ring, this ring may be optionally substiuted by one or, where possible, two substiutents. As will be appreciated, where Z represents oxadiazole, thiadiazole or terrazole ring, only one subsitutent will be possible; otherwise, one or two optional substituents may be accommodated around the five-membered heteroaromatic ring Z. Examples of suitable substituents on the fivemembered heteroaromatic ring Z include Cl-6 alkyl, C2.6alkenyl, C2.
6alkylnyl, C3-7 cycloalkyl, aryl, aryl (C 1-6) alkyl, C3-7 heterocycloalkyl, heteroaryl; (C1-6) alkyl, C1-6alkoxy, Cl.6alkylthio, amino, Cl.
6alkylamino, diCl.6alkylamino, halogen, cyano, and trifluoromethyl.
Still further, the present invention is also directed to the novel intermediates of structural formulae (IV) and (V).
DETAILED DESCRIPTION OF THE INVENTION
By this invention, there is provided a process comprising the step of contacting a compound of Structure I with a compound of
Structure II to form a compound of Structurem:
wherein Y is selected from Br, I, and triflate, and
R, R2, R3, R4, R5, and R6 are each substituents that will
not interfere with the reaction conditions.
More particularly, the present invention relates to the reaction above wherein:
Y is selected from Br, I and triflate;
R, R2, R3 and R4 are each independently selected from:
(1) hydrogen;
(3) C1 6 alkyl; (4) -(CH2)n-Z
wherein Z represents:
(a) fluoro,
(b) cyano,
(c) triazole,
(d) nitro,
(e) trifluoromethyl,
(f) -OR7, (g) -OCOR7,
(h) -OCONR7R8, (i) -OCH2CN,
(j) -OCH2CONR7R8,
(k) -SR7,
(1) -SOR7, (m) -SO2R7, (n) -So2NR7R8, (o) -NR7R8, (P) -NR7COR8, (q) -NR7CO2R8, (r) -NR7SO2R8, (s) -COR7, (t) -CO2R7, (u) -CONR7R8, Or a group of formula (Za), (Zb), (Zc), or (Zd):
or Z represents an optionally substituted five-membered
heteroaromatic ring selected from furan, thiophene,
pyrrole, oxazole, thiazole, isoxazole, isothiazole,
imidazole, pyrazole, oxadiazole, thiadiazole, triazole
and tetrazole;
R5 and R6 are each independently selected from:
(1) hydrogen,
(2) C1-6 alkyl,
(3) -CO2CH2CH3,
(4) 1,4-dioxaspiro, and
(5) Cl -6 alkyl substituted with R 10; R7 and R8 are each independently selected from:
(1) hydrogen,
(2) C1-6 alkyl,
(3) trifluoromethyl,
(4) phenyl, optionally substituted with one or more R20
substituents
(5) methylphenyl, optionally substituted with one or more
R20 substituents, and
(6) an arylC1-6alkyl- or heteroaryl C1-6alkyl- group.
optionally substituted with one or more R20
substituents, or
R7and R8 when linked through a nitrogen atom, together
represent the residue of an optionally substituted
azetidine, pyrrolidine, piperidine, morpholine or
piperazine ring, optionally substituted with one or
more R13 substituents;
R9 is selected from: (1) hydrogen, and
(2) C1-4 alkyl;
R10is selected from:
(1) halogen,
(2) cyano,
(3) trifluoromethyl,
(4) Cl 6alkyl, (5) haloCl 6alkyl-, (6) aryl,
(7) triazolyl,
(8) tetrazolyl,
(9) Cl 6alkyl-tetrazolyl-,
(10) hydroxy,
(11) C1 -6alkoxy-, (12) Cl 6alkylthio-,
(13) C2 6alkoxycarbonyl-, (14) C2 6alkylcarbonyl-,
(15) C1 6alkylsulphonyl-,
(16) arylsulfonyl-,
(17) amino-,
(18) Cl 6alkylamino-, (19) diC 1 6alkylamlno-, (20) diC 1 6alkylaminomethyl-, (21) C2-6alkylcarbonylamino-, (22) arylcarbonylamino-, (23) C2-6alkoxycarbonylamino-, (24) N-C1-6alkyl-N-C2-6alkoxyamino-, (25) carbonylamino-, (26) mono- or diarylaminocarbonylamino-, (27) pyrrolidinylcarbonylamino-, (28) piperidinylcarbonylamino-, (29) aminocarbonyl-, (30) aminocarbonylamino-, (31) C1-6alkylaminocarbonyl-, (32) C1 6alkylaminocarbonylamino-, (33) diC1-6alkylaminocarbonyl-, (34) diC1-6alkylaminocarbonylamino-, (35) pyrrolidinylcarbonylamino-, (36) piperidinylcarbonylamino-, (37) aminosulfonyl-, (38) C1-6alkylaminosulfonyl-, (39) C1-6alkylsulfonylamino-, (40) C1 6alkylsulfonylaminomethyl-, (41) arylsulfonylamino-, (42) diC 1 6alkylaminosulfonyl-, (43) aminosulphonylmethyl-, (44) C1-6alkylaminosulfonylmethyl-, and (45) diC 1 6alkylaminosulfonylmethyl-, (46) -(CH2)mOR11, (47) -(CH2)mSR11, (48) -(CH2)mSOR11 (49) -(CH2)mSO2R11, (50) -(CH2)mNR11R12, (51) =0, and
R11 and R12 are each independently selected from
(1) hydrogen,
(2) Cl 6alkyl, (3) C3 7cycloalkyl, (4) C3-7cycloalkylC1-6alkyl-,
(5) indanyl,
(6) aryl,
(7) arylC1-6alkyl-,
(8) C3-7heterocycloalkyl-,
(9) C3-7heterocycloalkylC1-6alkyl-,
(10) heteroaryl, and
(11) heteroarylC1-6alkyl-;
R13 is selected from:
(1) C1 -6alkyl, (2) arylC1-6alkyl-,
(3) C1 6alkoxy-, (4) C2 6alkyoxycarbonyl-, and
(5) C1-6alkylaminocarbonyl;
X1 and X2 are each independently selected from ring nitrogen or
ring carbon atoms;
X3 is selected from the group consisting of oxygen, sulfur, -NH- or
methylene;
yl is oxygen or sulfur;
n is an integer independently selected at each occurrence from
from 0 and 1; and m is an integer selected independetlyat each occurrence from 0 to
4.
Combinations of substituents and/or variables are permissible only if such combinations result in stable compounds.
In one embodiment of the present invention, R1, R3, and R4 are each hydrogen and R2, R5, R6 and Y are as defined above.
The term "triflate" or "OTf' refers to the trifluoromethane sulfonyl group.
When an amine is included as a substituent on a compound in the present invention, in order to optimize the conditions of the reaction and to obtain better yields, the amine may have to be protected, as is known in the art, and the protecting group removed following the coupling reaction.
When a carbonyl group is included as a substituent on a compound in the present invention, in order to optimize the conditions of the reaction and to obtain better yields, the carbonyl group may have to be protected, as is known in the art, and the protecting group removed following the coupling reaction.
As used herein "alkyl", particularly the expression "C1 6 alkyl", includes methyl and ethyl groups and straight chained or branched propyl, butyl, pentyl and hexyl groups. Particular alkyl groups are methyl, ethyl, n-propyl, isopropyl and t-butyl. Derived exeressions such as C1.6alkyoxy, C1-6alkylthio, and C1-6alkyl amino are to be construed accordingly.
The expression "C2-galkenyl" as used herein refers to straight chained and branched alkenyl groups containing from 2 to 6 carbon atoms. Typical examples include vinyl, allyl, dimethylallyl and butenyl groups.
The expression "C2 6alkynyl" as used herein refers to straight-chained and branched alkynyl groups containing from 2 to 6 carbon atoms. Typical examples include ethynyl and propargyl groups.
Typical C3 7cycloalkyl groups include cycloproyl, cyclobutyl, cyclopentyl and cyclohexyl.
Typical aryl groups include phenyl and naphthyl. More particularly, aryl is phenyl.
Particular indanyl groups include indan-1-yl and indan-2-yl.
Paricular arylCl 6alkyl groups include benzyl, phenylethyl, phenylpropyl and naphthylmethyl.
Suitable heterocycloalkyl groups include azetindinyl, pyrrolidinyl, piperidyl, piperazinyl and morpholinyl.
Suitable heteroaryl groups include pyridyl, quinolyl, isoquinolyl, pyridazinyl, pyrimidinyl, pyrazinyl, pyranyl, furyl, benzofuryl, dibenzofurtyl, thienyl, benzthienyl, pyrrolyl, indolyl, pyrazolyl, indazoloyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, imidazolyl, benzimidazolyl, oxadiazolyl, thiadiazolyl, triazolyl, and terazolyl groups.
The expression "heteroaryl C1-6alkyl" as used herein includes furylmethyl, furylethyl, thienylmethyl, thienylethyl, oxazolylmethyl, oxazolylethyl, thiazolylmethyl, thiazolylethyl., imidiazolylmethyl, imidazolylethyl, oxadiazolylmethyl, oxadiazolylethyl, thiadiazolylmethyl, thiadiazolylethyl, triazolylmethyl, triazolylethyl, tetrazolylmethyl, tetrazolylethyl, pyridylmethyl, pyridylethyl, pyridinylmethyl, pyrazinylmethyl, quinolylmethyl, and isoquinolylmethyl.
The term "halogen" as used herein includes fluorine, chlorine, bromine and iodine, especially fluorine, unless otherwise specified.
The process of the present invention is preferably carried out in a dry organic solvent inert for the starting materials in the presence of a palladium catalyst, and in the presence of an inorganic or organic base which is not a "catalyst poison". Preferably, the present process is carried out at an elevated temperature.
In the process of the present invention, Structure I is coupled with Structure II to form Structure m via a palladium catalyzed reaction in a dry inert organic solvent containing a soluble palladium catalyst and in the presence of a proton acceptor, being an aromatic amine, alkylamine or inorganic base, which is not a "catalyst poison," at a temperature of about 90-120"C.
The organic solvent useful in the process of the present invention must be one in which Structure I, Structure II and the palladium catalyst are soluble and compatible and is chemically inert under the reaction conditions. Preferred are DMSO (dimethylsulfoxide) and amide solvents such as DMF (dimethylfuran), DMAC (N,Ndimethylacetamide), and NMP (N-methyl-pyrrolidinone. Most preferred is DMF.
The alkyl ketone of structural formula (II) is generally employed in excess based on the the 2-halo- or 2-(OTf)- aniline of structural formula (1). A useful range is about 1.0 to 3 fold excess, based on the 2-halo- or 2-(OTf)- aniline of structural formula I. The alkyl ketone may be favorably employed at a two-fold excess, based on the 2halo- or 2-(OTf)- aniline of structural formula I.
The proton acceptor useful in the process of the present invention is a basic compound which can be organic or inorganic and acts as a proton acceptor and is not a "catalyst poison". By the term "catalyst poison" is meant interaction with the catalyst to inhibit its catalytic activity and prevent the coupling/ring closure between structures I and 11 from occurring. Suitable classes of proton acceptors include alkylamines, aromatic amines, heterocyclic gamines, and phosphates. Alkylamines are the preferred proton acceptor in the process of the present invention.
Particular alkylamines that may be employed include: DABCO (1,4 diazabicyclo[2.2.2]octane), quinuclidine, butylamine, and di-t-butylamine. DABCO is particularly preferred because it reduces the appearance of impurities in the reaction because it is resistant to oxidation to the imine in the reaction conditions of the process of the present invention.
The proton acceptor is generally employed in in excess based on the the 2-halo- or 2-(OTf)- aniline of structural formula (I). A useful range is about 2 to 4 fold excess, based on the 2-halo- or 2-(OTf)aniline of structural formula (I). The proton acceptor may be favorably employed at a three-fold excess, based on the 2-halo- or 2-(OTf)- aniline of structural formula (I).
The palladium catalyst useful in the reaction can be selected from the following classes: Pd alkanoates, Pd acetonates, Pd halides, Pd halide complexes, Pd-benzylidine acetone complexes, as well as triaryl
Pd phosphine complexes. Representative examples include, but are not limited to: Pd(ll) acetate, Pd(II) acetylacetonate, Pd(O)bid-dibenzylidene acetone ("dba"), Pd(II) bromide, Pd(II) chloride, Pd(ll) iodide, Pd(ll) sulfate, Pd(II)trifluoro acetate, Pd(ll) C12(CH3CN)2, Pd2 (dba)3, and Pd(u)C12(PhCN)2. A useful catalyst is palladium acetate.
The palladium catalyst is employed in an amount of about 0.5 to 5 mole percent based on the 2-halo- or 2-(OTf)- aniline of structural formula I. A useful range is about 2 to 3 mole percent of soluble palladium catalyst, based on the 2-halo- or 2-(OTf)- aniline of structural formula I.
A dehydrating agent, such as magnesium sulfate or molecular sieves may also be favorably employed in the process of coupling Structure I with Structure II to form Structure m according to the present invention.
The reaction is carried out in the temperature range of 90 to 1200C. A useful temperature is about 100-105"C. Generally, the reaction is carried out under a dry, inert atmosphere at atmospheric pressure. It is useful to carry out the reaction under a nitrogen atmosphere.
The progress of the reaction may be monitored by means known in the art, including thin-layer silica gel chromatography (TLC), high pressure liquid chromatography (HPLC), gas chromatography (GC), and nuclear magnetic resonance spectroscopy (NMR). Preferably HPLC or TLC is employed, most preferably HPLC. When the reaction is complete, generally in 8 to 72 hours, the reaction mixture is cooled to room temperature and the product is separated by traditional means, e.g.
by taking up with organic solvent, such as isopropyl acetate and washing with water and/or other aqueous solutions. The product may then be purified by means known in the art, including preparative thin-layer silica chromatography, silica gel chromatography, HPLC, crystallization, and solid-phase extraction. Preferably, the product is purified by silica gel chromatography or crystallization.
Particular compounds according to structural formula (I) that may be made according to the process of the present invention include:
A preferred compound that may be prepared according to the process of the present invention is:
Still further, the present invention is also directed to the novel intermediates of structural formulae (IV) and (V).
wherein R 1, R2, R3, R4, R5, R6,and Y are as defined above.
The 2-halo and 2-(OTf)- anilines and alkyl ketones employed in the processes of the present invention may be synthesized according to procedures well-known in the art, many are available commercially.
The following examples are not intended to be limitations on the scope of the instant invention in any way, and they should not be so construed. Furthermore, the compounds described in the following examples are not to be construed as forming the only genus that is considered as the invention, and any combination of the compounds or their moieties may itself form a genus. Those skilled in the art will readily understand that known variations of the conditions and processes of the following preparative procedures can be used to prepare these compounds.
EXAMPLES
EXAMPLE 1
Preparation of Indomethacin precursor
A mixture of 2-iodoaniline (10 mmol), 4-oxo-pentanoic acid (30 mmol), DABCO (30 mmol) and Pd(OAc)2 (0.5 mmol) in dry DMF (30 mL) are degassed via vacuum/nitrogen and heated to 105 "C. The mixture is heated at 105"C until the completion of the reaction. The mixture is cooled to room temperature and partitioned between 150 mL of isopropyl acetate (IPAc) and 50 mL of water. The organic layer is separated, washed with 50 mL of brine and concentrated in vacuum to dryness. The residues are chromatographed.
While the invention has been described and illustrated with reference to certain particular embodiments thereof, those skilled in the art will appreciate that various changes, modifications and substitutions can be made therein without departing from the spirit and scope of the invention. For example, effective dosages other than the particular dosages as set forth herein above may be applicable as a consequence of variations in the responsiveness of the mammal being treated for any of the indications for the compounds of the invention indicated above.
Likewise, the specific pharmacological responses observed may vary according to and depending upon the particular active compound selected or whether there are present pharmaceutical carriers, as well as the type of formulation and mode of administration employed, and such expected variations or differences in the results are contemplated in accordance with the objects and practices of the present invention. It is intended, therefore, that the invention be defined by the scope of the claims which follow and that such claims be interpreted as broadly as is reasonable.
Claims (19)
1. A process for preparing a compound of structural formula m
wherein
R1, R2, R3, R4, R5, and R6 are each substituents that will
not interfere with the reaction conditions, provided that R6 is
not H, comprising reacting a compound of structural formula I with a
compound of structural formula II:
wherein Y is selected from Br, I, and triflate, and
R1, R2, R3, R4, R5, and R6 are as defined above, in the presence of a palladium catalyst and a proton acceptor.
2. The process according to Claim 1 wherein:
Y is selected from Br, I and triflate;
R1, R2, R3 and R4 are each independently selected from:
(1) hydrogen;
(3) C1-6 alkyl; (4) -(CH2)n-Z
wherein Z represents:
(a) fluoro,
(b) cyano,
(c) triazole,
(d) nitro,
(e) trifluoromethyl,
(f) -OR7,
(g) -OCOR7, (h) -OCONR7R8,
(i) -OCH2CN,
(j) -OCH2CONR7R8,
(k) -SR7, provided that R7 is not H,
(1) -S OR7, (m) -SO2R7,
(n) -SO2NR7R8, (o) -NR7R8,
(p) -NR7COR8,
(q) -NR7CO2R8,
(r) -NR7SO2R8,
(s) -COR7,
(t) -CO2R7,
(u) -CONR7R8,
or Z is a group of formula (Za), (Zb), (Zc), or (Zd):
or Z represents an optionally substituted five-membered
heteroaromatic ring selected from furan, thiophene,
pyrrole, oxazole, thiazole, isoxazole, isothiazole,
imidazole, pyrazole, oxadiazole, thiadiazole, triazole
and tetrazole;
R5 is selected from:
(1) hydrogen,
(2) C16 alkyl,
(3) -CO2C1-6alkyl,
(4) 1,3-dioxaspiro,
(5) -S(O)pC1 -6 alkyl, and
(6) C1-6 alkyl substituted with R10;
R6 is selected from:
(1) C1-6 alkyl,
(2) -C02Cl 6alkyl, (3) 1,3-dioxaspiro,
(4) -S(O)pC1-6 alkyl, and
(5) C1-6 alkyl substituted with R10;
R7 and R8 are each independently selected from:
(1) hydrogen,
(2) C1-6 alkyl,
(3) trifluoromethyl,
(4) phenyl, optionally substituted with one or more R13
substituents,
(5) methylphenyl, optionally substituted with one or more
R13 substituents, and
(6) an arylC1-6alkyl- or heteroaryl C1-6alkyl- group.
optionally substituted with one or more R13
substituents, or
R7and R8 when linked through a nitrogen atom, together
represent the residue of an optionally substituted
azetidine, pyrrolidine, piperidine, morpholine or
piperazine ring, optionally substituted with one or
more R13 substituents;
R9 is selected from:
(1) hydrogen, and
(2) C1-4 alkyl;
R10 is selected from:
(1) halogen,
(2) cyano,
(3) trifluoromethyl,
(4) C1 6alkyl, (5) haloCl 6alkyl-, (6) aryl,
(7) triazolyl,
(8) tetrazolyl,
(9) C1-6alkyl-tetrazolyl-,
(10) hydroxy,
(11) C1-6alkoxy-,
(12) C1-6alkylthio-,
(13) C1 .6alkoxycarbonyl-, (14) Ci -6alkylcarbonyl-, (15) C1 -6alkylsulphonyl-,
(16) arylsulfonyl-,
(17) amino-,
(18) Cl.6alkylamino-, (19) diC1-6alkylamino-,
(20) diC1-6alkylaminomethyl-, (21) C1-6alkylcarbonylamino-, (22) arylcarbonylamino-, (23) Cl 6alkoxycarbonylamino-, (24) N-C1-6alkyl-N-C2-6alkoxyamino-, (25) carbonylamino-, (26) mono- or diarylaminocarbonylamino-, (27) pyrrolidinylcarbonylamino-, (28) piperidinylcarbonylamino-, (29) aminocarbonyl-, (30) aminocarbonylamino-, (31) C1-6alkylaminocalbonyl-, (32) C1-6alkylaminocarbonylamino-, (33) diC1-6alkylaminocarbonyl-, (34) diC 1 -galkylaminocarbonylamino-, (35) pyrrolidinylcarbonylamino-, (36) piperidinylcarbonylamino-, (37) aminosulfonyl-, (38) C1-6alkylaminosulfonyl-, (39) Ci 6alkylsulfonylamino-, (40) C1-6alkylsulfonylaminomethyl-, (41) arylsulfonylamino-, (42) diC 1 .6alkylaminosulfonyl-, (43) aminosulphonylmethyl-, (44) C1-6alkylaminosulfonylmethyl-, and (45) diC1-6alkylaminosulfonylmethyl-, (46) -(CH2)mOR11, (47) -(CH2)mSR1 1, provided that R11 is not H, (48) -(CH2)mSOR11 (49) -(CH2)mSO2R11, (50) -(CH2)mNR11R12, (51) =0, and (52) carbonyloxy-,
Rll and R12 are each independently selected from
(1) hydrogen,
(2) C1-6alkyl,
(3) C3 7cycloalkyl, (4) C3-7cycloalkylC1-6alkyl-,
(5) indanyl,
(6) aryl,
(7) arylC 1 -6alkyl-, (8) C3-7heterocycloalkyl-,
(9) C3-7heterocycloalkylC1-6alkyl-,
(10) heteroaryl, and
(11) heteroarylC1-6alkyl-;
R13 is selected from:
(1) C1-6alkyl,
(2) arylC1-6alkyl-, (3) Cl-6aIkoxy-, (4) C2 6alkyoxycarbonyl-, and
(5) Cl 1 6alkylaminocarbonyl;
X1 and X2 are each independently selected from ring nitrogen or
ring carbon atoms;
X3 is selected from the group consisting of oxygen, sulfur, -NH- or
methylene; yl is oxygen or sulfur; n is an integer independently selected at each occurrence from 0 to
1; m is an integer selected independently at each occurrence from 0 to
4, and p is an integer selected independently at each occurrence from 0, 1
and 2.
3. The process according to Claim 2 wherein R1, R3, and R4 are each hydrogen.
4. The process according to Claim 1 wherein the palladium catalyst is selected from: a palladium alkanoate, a palladium acetonate, a palladium halide, a palladium halide complex, a palladiumbenzylidine acetone complex and a triarylphosphine palladium complex.
5. The process according to Claim 4 wherein the palladium catalyst is selected from: Pd(II) acetate, Pd(u) acetylacetonate, Pd(O)bis-dibenzylidene acetone ("dba"), Pd(II) bromide, Pd(1I) chloride, Pd(II) iodide, Pd(U) sulfate, Pd(H)trifluoroacetate, Pd(II) Cl2(CH3CN)2, Pd2 (dba)3, and Pd(H)Cl 2(PhCN)2.
6. The process according to Claim 5 wherein the palladium catalyst is Pd(II) acetate.
7. The process according to Claim 1 wherein the proton acceptor does not interact with the palladium catalyst to inhibit its catalytic activity.
8. The process according to Claim 7 wherein the proton acceptor is selected from:
(a) an alkylamine,
(b) an aromatic amine,
(c) a heterocyclic amine, and
(d) a phosphate.
9. The process according to Claim 8 wherein the proton acceptor is an alkylamine.
10. The process according to Claim 9 wherein the alkylamine is selected from:
(a) 1,4-diazobicyclo[2.2.2]octane,
(b) 2,2,6,6-tetramethylpiperidine
(c) quinuclidine,
(d) t-butylamine, and
(e) di-t-butylamine.
11. The process according to Claim 10 wherein the alkylamine is 1 ,4-diazobicyclo[2.2.2] octane.
12. The process according to Claim 1 wherein the reaction is carried out in a dry organic solvent inert for the starting materials.
13. The process according to Claim 12 wherein the solvent is selected from:
(a) DMSO,
(b) DMF,
(c) DMAC, and
(d) NMP.
14. The process according to Claim 13 wherein the solvent is DMF.
15. The process according to Claim 1 wherein the reaction is carried out at a temperature of 90"C to 1200C.
16. The process according to Claim 15 wherein the temperature is 100"C to 105"C.
17. The process according to Claim 1 wherein the compound according to structural formula m is selected from:
wherein: R is-2-quinolinylmethyl, and
18. The compounds of structural formulae (IV) and (V):
wherein R, R, R , R4, R5, R6 and Y are as defined in Claim 1.
19. The compounds of structural formulae ('V) and (V):
wherein R, R2, R3, R4, R5, R6 and Y are as defined in Claim 2.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2387296P | 1996-08-13 | 1996-08-13 | |
| US2934496P | 1996-10-31 | 1996-10-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB9716979D0 GB9716979D0 (en) | 1997-10-15 |
| GB2316404A true GB2316404A (en) | 1998-02-25 |
Family
ID=26697715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9716979A Withdrawn GB2316404A (en) | 1996-08-13 | 1997-08-11 | Palladium catalysed indolization |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2316404A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150005494A1 (en) * | 2011-12-19 | 2015-01-01 | Nanyang Technological University | Processes for preparing indoles |
-
1997
- 1997-08-11 GB GB9716979A patent/GB2316404A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150005494A1 (en) * | 2011-12-19 | 2015-01-01 | Nanyang Technological University | Processes for preparing indoles |
| US9334275B2 (en) | 2011-12-19 | 2016-05-10 | Nanyang Technological University | Processes for preparing indoles |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9716979D0 (en) | 1997-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | A facile and efficient procedure for one-pot four-component synthesis of polysubstituted spiro pyrano [2, 3-c] pyrazole and spiro 1, 4-dihydropyridine catalyzed by a Dabco-based ionic liquid under mild conditions | |
| GB2316405A (en) | Palladium Catalysed indolization | |
| US5877329A (en) | Palladium catalyzed indolization | |
| CN113880750B (en) | Synthesis method of chiral 3-substituted-3-aryl oxindole compound | |
| US7332614B2 (en) | Process for cross coupling indoles | |
| Moghaddam et al. | Diastereoselective construction of a functionalized dihydro-pyridazine-based spirooxindole scaffold via C-3 umpolung of isatin N, N′-cyclic azomethine imine | |
| Karpov et al. | A diversity oriented four-component approach to tetrahydro-β-carbolines initiated by Sonogashira coupling | |
| GB2295615A (en) | Pyrrolo-pyridine derivatives | |
| CN108863890B (en) | 4-pyrroline-2-ketone derivative and preparation method thereof | |
| Kumar Saini et al. | I2‐DMSO‐Mediated Cascade Cyclization of β‐Ketosulfoxonium Ylides and β‐Enaminones: Synthesis of Quaternary‐Carbon‐Centered 2‐Hydroxy‐pyrrol‐3 (2H)‐ones | |
| Karpov et al. | A novel one-pot four-component access to tetrahydro-β-carbolines by a coupling-amination-aza-annulation-Pictet–Spengler sequence (CAAPS) | |
| Jones et al. | Direct synthesis of 2-acylindoles | |
| EP0925302B1 (en) | Palladium catalyzed indolization | |
| GB2316404A (en) | Palladium catalysed indolization | |
| JP4208464B2 (en) | Method for producing naphthyridine-3-carboxylic acid derivative | |
| Welch | Synthesis of 2-Benzyl-4-phenyl-2, 4-dihydropyrrolo [3, 4-b] indole | |
| WO2024031753A1 (en) | Indoline compound and preparation method therefor | |
| NO179517B (en) | Process for the preparation of 8-chloroquinolone derivatives | |
| Korytnyk et al. | Vitamin B6 antagonists obtained by replacing or modifying the 2-methyl group | |
| KR100498004B1 (en) | Novel process for the preparation of a quinoline carboxylic acid derivative having a 7-(4-aminomethyl-3-oxime)pyrrolidine substituent | |
| SU564813A3 (en) | Method for obtaining derivatives of indoloquinolysine or their salts | |
| US3882119A (en) | Tetracyclic substituted phthalazine compounds | |
| HU187471B (en) | Process for preparing n-acyl-triptamine derivatives and pharmaceutical compositions containing them as active agents | |
| KR900007197B1 (en) | Process for preparing 1-acyl-2-pyrazoline derivatives | |
| CN115232063B (en) | Synthesis method of polysubstituted benzo [ c, d ] indole compound containing bromine or chlorine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |